CKD STAGE 5

Clinical trials for CKD STAGE 5 explained in plain language.

Never miss a new study

Get alerted when new CKD STAGE 5 trials appear

Sign up with your email to follow new studies for CKD STAGE 5, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can a common diabetes drug shield failing kidneys?

Disease control Ongoing

This study tests canagliflozin, a drug typically used for diabetes, in people with advanced chronic kidney disease (stages 4 and 5) including those on dialysis. The goal is to see if it safely reduces protein in the urine, a marker of kidney damage, and to measure how the drug be…

Matched conditions: CKD STAGE 5

Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control

Last updated May 18, 2026 12:02 UTC

CKD STAGE 5

Get alerted when new CKD STAGE 5 trials appear

Can a common diabetes drug shield failing kidneys?